BSE FMCG Sector Regulatory Filings — May 02, 2026

Equity shareholders meeting proceeded post-quorum adjournment, concluding at 12:15 PM IST on May 02, 2026, indicating shareholder engagement in Sesa Care amalgamation

Unsecured creditors meeting concluded at 01:43 PM IST after quorum met, supporting merger approval process with no disruptions post-adjournment

Remote e-voting enabled from April 28 (09:00 AM IST) to May 01 (05:00 PM IST) via NSDL, plus in-meeting voting, enhancing participation in high materiality (8/10) scheme

Consistent procedural execution across two filings for same event, per NCLT New Delhi order dated March 12, 2026, signals management commitment to timeline

No prior disruptions noted in sequence of intimations (April 01, March 31, etc., back to May 26, 2025), showing steady progress toward amalgamation

VC/OAVM format used effectively for meetings, aligning with regulatory norms and facilitating broad stakeholder access in FMCG sector M&A

High materiality (8/10) on both filings underscores strategic value of Sesa Care integration for FMCG portfolio expansion

Neutral sentiment with no negative procedural flags post-quorum, relative to potential sector M&A delays, positions Dabur as outperformer in process efficiency

Brief 30-minute adjournment resolved quickly in both shareholder and creditor meetings, minimizing delays vs. typical NCLT scheme risks

Filings confirm quorum achievement, a critical threshold for scheme approval, with no reported oppositions in summaries

Initial lack of quorum led to 30-minute adjournment in both equity shareholders and unsecured creditors meetings on May 02, 2026

No voting results or outcomes disclosed in either filing, leaving approval status ambiguous post-meetings

Dependence on NCLT New Delhi Bench post-meeting disclosures, with prior intimations spanning Dec 2025-May 2026 indicating extended process

Initial quorum shortfall in high materiality (8/10) meetings raises questions on initial turnout for Sesa Care scheme

Absence of period-over-period financial trends, insider activity, or synergies data in filings limits visibility into merger value

Sole FMCG filer on May 02, 2026, with neutral sentiment, may signal limited peer M&A momentum or Dabur-specific execution risks

Remote e-voting ended May 01, 2026, with no in-meeting issues noted but potential for low participation if quorum was borderline

Pending voting outcomes from May 02 meetings could unlock Sesa Care synergies, high materiality (8/10) for FMCG growth

Successful scheme progression per NCLT order offers alpha via portfolio diversification in consumer goods

Quick quorum resolution and meeting conclusions position Dabur ahead of typical NCLT delays, potential re-rating catalyst

Robust NSDL e-voting (April 28-May 01) suggests strong governance, attractive for long-term FMCG investors

Sequence of intimations since 2025 indicates disciplined execution, opportunity to front-run NCLT sanction

As lone BSE FMCG M&A filer, Dabur leads in inorganic plays, potential relative outperformance vs. stagnant peers

Next filings likely to reveal results, trading opportunity on approval vs. neutral sentiment now

Proven virtual meeting format reduces costs, opportunity in operational leverage for future schemes

2/2 filings focused on Dabur's Sesa Care amalgamation, high materiality (8/10 avg), signals early consolidation in BSE FMCG amid neutral sentiment

Both filings note initial quorum shortfalls resolved in 30 mins, common NCLT hurdle implying sector needs better stakeholder mobilization for schemes

Intimations spanning 2025-2026 highlight prolonged NCLT processes, pressuring FMCG firms' inorganic growth timelines vs. organic trends (no data)

Consistent NSDL remote + in-meeting voting across filings boosts participation, positive governance theme for BSE FMCG shareholder democracy

100% neutral across 2 filings, reflecting procedural nature but high materiality flags strategic shifts without financial PoP insights

Monitor BSE filings for May 02, 2026, meeting results on Sesa Care scheme approval, critical for merger catalyst

Track NCLT New Delhi sanction post-approval, per March 12, 2026 order, expected in coming weeks

Watch for post-meeting insider trades/pledges related to amalgamation conviction, no data in current filings

Upcoming filings for merger synergies, ratios, or PoP trends absent here, potential Q2 2026 earnings tie-in

Any oppositions or additional meetings post-May 02 conclusions, given initial quorum issues

Monitor other constituents for similar schemes, as Dabur's isolated activity may presage broader consolidation

Post-merger updates on dividends/buybacks impacted by Sesa Care integration, no details yet